5-Amino-1MQ (5-Amino-1-methylquinolinium) is a novel small molecule peptide classified as an NNMT inhibitor meaning it blocks the activity of the enzyme nicotinamide N-methyltransferase (NNMT), which plays a key role in cellular energy metabolism , fat storage , and aging
Integration with metals or polymers enable for precise modulation of optical, magnetic, and surface properties, improving effectiveness in imaging, biosensing, and targeted drug delivery applications [180, 181]
"Conclusions of a WHO Technical Consultation on folate and vitamin B12 deficiencies"
The peptide was investigated by Australian pharmaceutical company Lateral Pharma as a potential management of migraines and neuropathic pain, but the results were similar to placebo [10, 11]
The company sponsored three separate clinical trials, all with fairly positive outcomes.29 However, its worth pointing out that the research has yet to be published or peer-reviewed
Greibe E, Miller JW, Foutouhi SH, Green R, Nexo E (2013) Metformin increases liver accumulation of vitamin B12 - an experimental study in rats
&srotate=0)
